Trial Profile
Effects Of The Administration Of Nebivolol Versus Carvedilol On Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection In Healthy Volunteers" (NeCaMic-study)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Carvedilol
- Indications Chronic heart failure; Hypertension
- Focus Pharmacodynamics
- Acronyms NeCaMic
- Sponsors Menarini Benelux
- 23 Oct 2019 Status changed from completed to discontinued.
- 10 Sep 2014 New trial record